Innoviva Inc
INVAHealthcare|Biotechnology|USA
$22.23
+0.04 (+0.20%)
DCF (FCF)
$42.29
Tangible Book
$15.56
Graham Number
$41.06
Earnings Power
$26.78
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (36)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner | 2025-03-06 | SELL | 1,618,295 | $17.55 | $28401.1K |
| Zhen Marianne | Chief Accounting Officer | 2023-11-15 | SELL | 10,994 | $13.99 | $153.8K |
| DENNER ALEXANDER J | 10% Owner | 2023-06-15 | BUY | 62,000 | $13.13 | $814.1K |
| DENNER ALEXANDER J | 10% Owner | 2023-06-06 | BUY | 15,000 | $13.05 | $195.8K |
| DENNER ALEXANDER J | 10% Owner | 2023-05-30 | BUY | 200,000 | $13.04 | $2608K |
| DENNER ALEXANDER J | 10% Owner | 2023-05-19 | BUY | 96,000 | $13.22 | $1269.1K |
| DENNER ALEXANDER J | 10% Owner | 2023-05-18 | BUY | 60,000 | $13.07 | $784.2K |
| DENNER ALEXANDER J | 10% Owner | 2023-05-11 | BUY | 290,000 | $12.34 | $3578.6K |
| Raifeld Pavel | CEO | 2023-03-10 | BUY | 3,000 | $10.87 | $32.6K |
| Zhen Marianne | Chief Accounting Officer | 2021-08-20 | SELL | 3,931 | $15.98 | $62.8K |
| Zhen Marianne | Chief Accounting Officer | 2021-08-20 | SELL | 1,129 | $15.89 | $17.9K |
| GLAXOSMITHKLINE PLC | 10% Owner | 2021-05-20 | SELL | 32,005,260 | $12.25 | $392064.4K |
| Zhen Marianne | Chief Accounting Officer | 2020-02-24 | SELL | 2,954 | $14.78 | $43.7K |
| Bickerstaff George | Director | 2019-02-27 | BUY | 15,000 | $15.9 | $238.5K |
| Zhen Marianne | Chief Accounting Officer | 2019-02-26 | SELL | 5,617 | $16 | $89.9K |
| Bickerstaff George | Director | 2019-02-21 | BUY | 10,000 | $14.9 | $149K |
| HULME GEOFFREY | Interim PEO | 2019-02-15 | BUY | 7,000 | $14.8 | $103.6K |
| ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 2018-08-21 | SELL | 8,000 | $14.11 | $112.9K |
| Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 2018-08-21 | SELL | 8,504 | $14.12 | $120.1K |
| dEsparbes Eric | SVP and CFO | 2018-05-21 | SELL | 5,808 | $14.4 | $83.6K |
| ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 2018-05-21 | SELL | 8,000 | $14.4 | $115.2K |
| dEsparbes Eric | Interim PEO, SVP and CFO | 2018-02-21 | SELL | 5,378 | $16.52 | $88.8K |
| Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 2018-02-21 | SELL | 9,890 | $16.6 | $164.2K |
| ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 2018-02-21 | SELL | 8,000 | $16.51 | $132.1K |
| Aguiar Michael W | President & Chief Exec Officer | 2017-12-04 | SELL | 12,022 | $13.13 | $157.8K |
| Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 2017-11-21 | SELL | 13,000 | $13.29 | $172.8K |
| ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 2017-11-21 | SELL | 5,215 | $13.26 | $69.2K |
| dEsparbes Eric | SVP and CFO | 2017-11-21 | SELL | 15,285 | $13.28 | $203K |
| dEsparbes Eric | SVP and CFO | 2017-08-21 | SELL | 1,825 | $12.2 | $22.3K |
| Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 2017-05-22 | SELL | 7,815 | $12.01 | $93.9K |
| dEsparbes Eric | SVP and CFO | 2017-05-22 | SELL | 1,825 | $11.85 | $21.6K |
| dEsparbes Eric | SVP and CFO | 2017-02-21 | SELL | 1,825 | $12.07 | $22K |
| WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | 2016-11-22 | SELL | 3,700 | $10.84 | $40.1K |
| dEsparbes Eric | SVP and CFO | 2016-11-21 | SELL | 1,800 | $10.89 | $19.6K |
| dEsparbes Eric | SVP and CFO | 2016-08-22 | SELL | 3,700 | $11.77 | $43.5K |
| Tyree James L | Director | 2016-05-18 | SELL | 813 | $10.47 | $8.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked